Cargando…

The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype

Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent. We have here tested fusion DNA vaccines which encode proteins that bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grødeland, Gunnveig, Mjaaland, Siri, Tunheim, Gro, Fredriksen, Agnete B., Bogen, Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823800/ https://www.ncbi.nlm.nih.gov/pubmed/24244595 http://dx.doi.org/10.1371/journal.pone.0080008

Ejemplares similares

Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines
por: Grødeland, Gunnveig, et al.
Publicado: (2015)

Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief
por: Andersen, Tor Kristian, et al.
Publicado: (2021)

Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza
por: Tjärnhage, Elias, et al.
Publicado: (2023)

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease
por: Lambert, Laura, et al.
Publicado: (2016)

Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells
por: Fredriksen, Agnete B., et al.
Publicado: (2012)

A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza
por: Andersen, Tor Kristian, et al.
Publicado: (2017)

Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
por: Andersen, Tor Kristian, et al.
Publicado: (2019)

Increased Generation of HIV-1 gp120-Reactive CD8(+) T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3
por: Øynebråten, Inger, et al.
Publicado: (2014)

Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin
por: Grødeland, Gunnveig, et al.
Publicado: (2020)

P19-39. Vaccibodies: a novel vaccine strategy for HIV that target viral antigens to APC
por: Øynebråten, I, et al.
Publicado: (2009)

Detection of anti‐NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases
por: Robertson, Anna Hayman, et al.
Publicado: (2020)

Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study
por: Laake, Ida, et al.
Publicado: (2018)

Heterodimeric Barnase-Barstar Vaccine Molecules: Influence of One versus Two Targeting Units Specific for Antigen Presenting Cells
por: Spång, Heidi Cecilie Larsen, et al.
Publicado: (2012)

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness
por: Tunheim, Gro, et al.
Publicado: (2019)

Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection
por: Zhou, Fan, et al.
Publicado: (2021)

Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway
por: Mohn, Kristin G.-I., et al.
Publicado: (2015)

APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell Responses
por: Bjerkan, Louise, et al.
Publicado: (2021)

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023)

Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
por: Watle, Sara Viksmoen, et al.
Publicado: (2021)

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
por: Bjørlykke, Kristin H, et al.
Publicado: (2023)

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
por: Syversen, Silje Watterdal, et al.
Publicado: (2022)

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023)

The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study
por: Christensen, Ingrid Egeland, et al.
Publicado: (2022)

Single-molecule analysis of specificity and multivalency in binding of short linear substrate motifs to the APC/C
por: Hartooni, Nairi, et al.
Publicado: (2022)

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
por: Jyssum, Ingrid, et al.
Publicado: (2022)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

APC and MUTYH Analysis in FAP Patients: A Novel Mutation in APC Gene and Genotype-Phenotype Correlation
por: D’Elia, Giovanna, et al.
Publicado: (2018)

Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study
por: Trogstad, Lill, et al.
Publicado: (2021)

Different Phenotypic Consequences of Simultaneous Versus Stepwise Apc Loss
por: Fischer, Jared M, et al.
Publicado: (2011)

The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines
por: Keresztes, Gabor, et al.
Publicado: (2022)

Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer
por: Figer, A, et al.
Publicado: (2001)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients
por: Fostira, Florentia, et al.
Publicado: (2010)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Atomic-Resolution Structures of the APC/C Subunits Apc4 and the Apc5 N-Terminal Domain
por: Cronin, Nora B., et al.
Publicado: (2015)

A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza
por: Braathen, Ranveig, et al.
Publicado: (2020)

The importance of APC
por: Ablamunits, Vitaly
Publicado: (2005)

Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

Publisher Correction: Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jg8vt3c569fr5ik31pffvbq98o